Details of the Drug

General Information of Drug (ID: DMZNF59)

• Drug Name: US8536181, C14
• Synonyms: SCHEMBL271606; CHEMBL3649594; BDBM102338; US8536181, C14
• Drug Type: Small molecular drug
• #Ro5 Violations (Lipinski): 0:
  Molecular Weight (mw); 334.4
  Logarithm of the Partition Coefficient (xlogp); 3.1
  Rotatable Bond Count (rotbonds); 6
  Hydrogen Bond Donor Count (hbonddonor); 2
  Hydrogen Bond Acceptor Count (hbondacc); 3
• Chemical Identifiers:
  Formula: C21H22N2O2
  IUPAC Name: 1-benzyl-3-hydroxy-4-[(1-phenylethylamino)methyl]pyridin-2-one
  Canonical SMILES: CC(C1=CC=CC=C1)NCC2=C(C(=O)N(C=C2)CC3=CC=CC=C3)O
  InChI: InChI=1S/C21H22N2O2/c1-16(18-10-6-3-7-11-18)22-14-19-12-13-23(21(25)20(19)24)15-17-8-4-2-5-9-17/h2-13,16,22,24H,14-15H2,1H3
  InChIKey: VGDRCKOTQHHWTA-UHFFFAOYSA-N
• Cross-matching ID:
  PubChem CID: 9997015
  TTD ID: D0HN5O

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
HIF-prolyl hydroxylase 2 (HPH-2)	TT9ISBX	EGLN1_HUMAN	Inhibitor	[1]

References

• [1] Prolyl hydroxylase inhibitors. US8536181.